1.AbarelixFor palliative treatment of advanced prostate cancer.
2.AlfuzosinFor the treatment of the signs and symptoms of benign prostatic hyperplasia.
3.AminoglutethimideFor the suppression of adrenal function in selected patients with Cushing`s syndrome, malignant neoplasm of the female breast, and carcinoma in situ of the breast.
4.BicalutamideFor treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.
5.CapromabFor diagnosis of prostate cancer and detection of intra-pelvic metastases
6.CephalexinFor the treatment of respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes; otitis media due to Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Moraxella catarrhalis; skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes; bone infections caused by Staphylococcus aureus and/or Proteus mirabilis; genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae.
7.ChlorotrianiseneUsed to treat symptoms of menopause, deficiencies in ovary function (including underdevelopment of female sexual characteristics and some types of infertility), and in rare cases, prostate cancer. Chlorotrianisene may also be used to prevent breast engorgement following childbirth.
8.CiprofloxacinFor the treatment of the following infections caused by susceptible organisms: urinary tract infections, acute uncomplicated cystitis, chronic bacterial prostatitis, lower respiratory tract infections, acute sinusitis, skin and skin structure infections, bone and joint infections, complicated intra-abdominal infections (used in combination with metronidazole), infectious diarrhea, typhoid fever (enteric fever), uncomplicated cervical and urethral gonorrhea, and inhalational anthrax (post-exposure).
9.Conjugated EstrogensFor the treatment of moderate to severe vasomotor symptoms associated with the menopause, atrophic vaginitis, osteoporosis, hypoestrogenism due to hypogonadism, castration, primary ovarian failure, breast cancer (for palliation only), and Advanced androgen-dependent carcinoma of the prostate (for palliation only)
10.CyproteroneFor the palliative treatment of patients with advanced prostatic carcinoma.
11.DiethylstilbestrolUsed in the treatment of prostate cancer. Previously used in the prevention of miscarriage or premature delivery in pregnant women prone to miscarriage or premature delivery.
12.DocetaxelFor the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy. Also used as a single agent in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy. Lastly, for use, in combination with prednisone, in the treatment of patients with androgen independent (hormone refractory) metastatic prostate cancer.
13.DoxazosinFor treatment and management of Hypertension and urinary obstruction symptoms of BPH.
14.DutasterideFor the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate gland.
15.Epothilone DInvestigated for use/treatment in colorectal cancer, lung cancer, breast cancer, solid tumors, and prostate cancer.
16.EstramustineFor the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate
17.Ethinyl EstradiolFor treatment of moderate to severe vasomotor symptoms associated with the menopause, female hypogonadism, prostatic carcinoma-palliative therapy of advanced disease, breast cancer, as an oral contraceptive, and as emergency contraceptive.
18.FinasterideFor the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms, reduce the risk of acute urinary retention, reduce the risk of the need for surgery including transurethral resection of the prostate.
19.FlavoxateFor symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.
20.FlutamideFor the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate
21.GoserelinBreast cancer; Prostate carcinoma; Endometriosis
22.LeuprolideFor treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty
23.MegestrolFor the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used to treat breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.
24.MethyltrienoloneNot available
25.N-(4-Hydroxyphenyl)All-Trans RetinamideNot available
26.NilutamideFor use in combination with surgical castration for the treatment of metastatic prostate cancer (Stage D2)
27.OrlistatFor obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. Also used to reduce the risk for weight regain after prior weight loss.
28.ParicalcitolFor treatment of secondary hyperparathyroidism associated with chronic kidney disease (CKD) Stage 3 and 4
29.PhenoxybenzamineFor the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension.
30.PrazosinFor treatment of hypertension and chronic heart failure.
31.QuinestrolUsed in hormone replacement therapy, treating symptoms of menopause such as hot flashes. Also used to treat breast and prostate cancer.
32.SulfamethoxazoleFor the treatment of bronchitis, prostatitis and urinary tract infections.
33.TamsulosinUsed in the treatment of signs and symptoms of benign prostatic hyperplasia.
34.TemafloxacinFor the treatment of lower respiratory tract infections, genital and urinary infections like prostatitis, and skin infections.
35.TerazosinFor the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.
36.Vitamin EVitamin E, known for its antioxidant activities, is protective against cardiovascular disease and some forms of cancer and has also demonstrated immune-enhancing effects. It may be of limited benefit in some with asthma and rheumatoid arthritis. It may be helpful in some neurological diseases including Alzheimer`s, some eye disorders including cataracts, and diabetes and premenstrual syndrome. It may also help protect skin from ultraviolet irradiation although claims that it reverses skin aging, enhances male fertility and exercise performance are poorly supported. It may help relieve some muscle cramps.
37.ZoledronateFor the treatment of hypercalcemia of malignancy. Also for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. In May of 2007, the drug was approved for treatment of Paget’s Disease.

© 2010-2020 All rights reserved. King Abdullah University of Science and Technology, All rights reserved